Drug Profile
Research programme: brain aminopeptidase A inhibitors - Quantum Genomics
Alternative Names: NI 929; QGC-006Latest Information Update: 28 Sep 2023
Price :
$50
*
At a glance
- Originator Quantum Genomics
- Class Amines; Disulfides; Sulfonic acids
- Mechanism of Action Glutamyl aminopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 28 Sep 2023 No recent reports of development identified for preclinical development in Hypertension in France (PO)
- 31 Aug 2019 Pharmacodynamics data from a preclinical study in Hypertension presented at the ESC Congress 2019: Annual Congress of the European Society of Cardiology (ESC-2019)
- 01 Aug 2019 Preclinical trials in Hypertension in France (PO), before August 2019